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A B S T R A C T
Background: Worldwide, the incidence of cutaneous melanoma has been reported to be highest in the
summer and lowest in the winter. Northern Irish data suggested seasonal variation for women only,
especially those with thinner melanomas, sited on limbs. We interrogated two larger UK cancer
registries for temporal differences in melanoma diagnosis and associated patient characteristics.
Methods: Melanomas diagnosed from 2006 to 2010 in the Eastern England and Scottish cancer registries
(n = 11,611) were analysed by month of diagnosis, patient demographics and melanoma characteristics,
using descriptive and multivariate modelling methods.
Results: More patients with melanoma were diagnosed in the summer months (June 9.9%, July 9.7%,
August 9.8%) than the winter months (December 7.2%, January 7.2%, February 7.1%) and this pattern was
consistent in both regions. There was evidence that the seasonal patterns varied by sex (p = 0.015),
melanoma thickness (p = 0.002), body site (p = 0.006), and type (superficial spreading melanomas
p = 0.005). The seasonal variation was greatest for diagnosis of melanomas occurring on the limbs.
Conclusion: This study has confirmed seasonal variation in melanoma diagnosis in Eastern England and
Scotland across almost all population demographics and melanoma characteristics studied, with higher
numbers diagnosed in the summer months, particularly on the limbs. Seasonal patterns in skin
awareness and related help-seeking are likely to be implicated. Targeted patient interventions to
increase sun awareness and encourage year-long skin inspection are warranted.
 2015 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).
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jou r nal h o mep age: w ww.c an cer ep idem io log y.n et1. Introduction
Cutaneous melanoma is now the fifth commonest cancer
diagnosed in the United Kingdom, following a rapid rise in
incidence over the last few decades. While 11 cases per 100,000
population were diagnosed in 1999–2001, the age-standardised
rate had increased by 55% to around 17 cases per 100,000
population in 2008–2010 [1]. The increase has been seen across
sex and age groups, but most significantly among older men* Corresponding author at: Strangeways Research Laboratory, Worts’ Causeway,
Cambridge CB1 8RN, UK. Tel.: +44 01223 762514.
E-mail address: fmw22@medschl.cam.ac.uk (F.M. Walter).
http://dx.doi.org/10.1016/j.canep.2015.06.006
1877-7821/ 2015 The Authors. Published by Elsevier Ltd. This is an open access artic[2]. Importantly, more than a quarter of new melanoma cases
were diagnosed in people aged less than 50 years in 2010, in
contrast to only 11% among all cancers combined [1].
It is possible that some of the increase in incidence may be due
to improved surveillance and earlier detection, as well as changes
in diagnostic criteria [3]. However, most of the increasing
incidence trends are considered to be due to exposure to ultra-
violet radiation through increased frequency of sunbed use,
intermittent unaccustomed exposure especially in childhood,
and leisure-time exposure including holidays abroad and outdoor
sport [4–6]. Approximately 86% of melanomas diagnosed in the UK
in 2010 were estimated to be linked to exposure to ultra-violet
radiation from the sun and sunbeds [7].le under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
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melanoma diagnosis worldwide. Among light-skinned populations
the incidence of melanoma is highest in summer and lowest in
winter, irrespective of latitude [8,9]. However, detailed analysis of
seasonal variation within the UK is limited to small datasets, and
only data collected up until 2006: in the Oxford Region using data
routinely collected between 1952 and 1975 [10], and in Northern
Ireland where an analysis of data collected between 1984 and
2006 confirmed seasonal variation for women only, especially those
with thinner melanomas and tumours diagnosed on the limbs [11].
We conducted an analysis of routinely collected clinical data
from the Eastern England and Scottish cancer registries between
2006 and 2010, and compared diagnosis by month of the year,
taking into account key factors including patient demographics as
well as melanoma characteristics relevant to predicting disease
outcome.
2. Materials and methods
2.1. Patient cohorts
We analysed routinely collected clinical data regarding invasive
cutaneous melanoma registered by the National Cancer Registra-
tion Service- Eastern Office and the Scottish Cancer Registry
between 1st January 2006 and 31st December 2010. While the
regions have a comparable population size at approximately
5.7 and 5.2 million respectively, they are geographically distinct
and have diverse socio-demographic characteristics. Primary
sources of information included electronic and paper-based
reports and clinical notes from hospitals and pathology laborato-
ries. Recent reports have highlighted the completeness of recorded
Breslow thickness for all melanomas, at more than 85% across both
registries since 2006 (CI5 Vol X).
We abstracted data items related to patient, disease and
temporal factors. Demographic variables included sex, age group at
diagnosis (two groupings were used: <30 years, 30–49, 50–64 year
and 65 years for comparison with crude incidence rates, and <50
years, 50–64 years, 65–74 years, 75 years for other analyses), and
national quintile of small area measures of deprivation (using
income domain of either the English or Scottish Index of Multiple
Deprivation as applicable).
Disease data included melanoma Breslow thickness, histologi-
cal type and body site of occurrence. Breslow thickness data were
split into two categories: <2 mm, and 2 mm. Breslow thickness
was reported in millimetres for 94% of the Scottish cases, and 89%
of the Eastern England cases (17 Eastern England cases had
Breslow thickness reported as group only). Histological types of
melanomas were categorised using the ICDO(3) morphology
codes: superficial spreading melanoma (SSM), nodular melanoma
(NM), lentigo maligna melanoma (LMM), unclassified/unknown
melanoma (UM) (codes 8720 NOS, 8723 NOS regressing), and
others (OM) (codes 8722 Balloon cell, 8730 Amelanotic, 8740 Ma-
lignant melanoma in junctional naevus, 8741 Malignant melano-
ma in precancerous melanosis, 8744 Acral lentiginous, 8745
Desmoplastic, 8746 Mucosal lentiginous melanoma, 8761 Melano-
ma arising in congenital melancytic naevus, 8770 Mixed epithelial
and spindle cell, 8771 Epithelioid cell melanoma, 8772 Spindle
cell NOS, 8780 Blue naevus malignant). Anatomical site was coded
using the International Classification of Diseases (ICD) 10 (four
digit) as follows: C430 (lip), C431 (eyelid), C432 (ear), C433 (other
and unspecified parts of face), and C434 (scalp and neck) were
located on ‘Head and Neck’; C435 corresponded to ‘Trunk’; C436 to
‘Upper Limb’; C437 to ‘Lower Limb’; C438 (other specified sites
of skin) and C439 (site unspecified) to ‘Other’ sites. Melanomas
occurring in the eye or genital organs, and in situ melanomas were
excluded.Temporal differences were characterised by the month and year
of melanoma diagnosis.
2.2. Statistical analysis
Initial descriptive analyses were undertaken to compare cases
per year between the two regions, and to compare stratified
Breslow thickness by patient demographics, tumour character-
istics, and month of diagnosis. Multivariate analyses were then
undertaken using a negative binomial regression to model the
number of cases diagnosed in each month (outcome). The main
exposure of interest was seasonal variation which was modelled
using sine and cosine components with a period of one year. The
model further included fixed effect exposures for sex, age,
deprivation, region, Breslow thickness (as a binary variable
<2 mm or 2 mm), site and histological type. Finally a longer
term trend in incidence was accounted for with a cubic spline with
3 knots (a pragmatic choice providing more flexibility than a linear
trend whilst remaining reasonably parsimonious). A negative
binomial model was used as initial investigations suggested that
more variation existed than suggested by the Poisson distribution
(i.e. there was over-dispersion). As with Poisson regression, the
negative binomial framework models counts rather than rates
and so an offset equal to the log of the person time at risk needs to
be included such that the outputs from the model may be
interpreted as rate ratios. To do so we use the population at risk in
each age by sex by deprivation group. This was calculated using
2008 national statistics aggregated up from the lower super
output area level (a lower super output area is a geographic region
defined for reporting of UK census data, each containing a
population of around 1500 people). When initially specifying the
model more complex parametrisations of seasonal variation were
considered, however, early investigations suggested that higher
order Fourier components did not significantly improve the fit of
the model.
In addition to considering the overall seasonal trend we were
also interested in whether the seasonal variation in incidence
was dependant on other factors. In order to investigate this we
considered interactions between the sine and cosine components
and other variables retaining only those found to be statistically
significant. Where more than one variable was found to have a
significant interaction, interactions between those variables were
also considered. As a supplementary analysis we repeated the
final regression model treating Breslow thickness as a 4 category
model (1 mm, 1–1.99 mm, 2–3.99 mm and 4 mm). Data
analysis was undertaken using Stata 13 (Stata Corporation, College
Station, TX).
3. Results
3.1. Sample description and incidence
A total of 11,611 invasive cutaneous melanoma cases were
registered in both regions from 2006 to 2010: 5998 in Eastern
England and 5613 in Scotland. The number of cases and crude
incidence is shown in Table 1 by year, patient demographics and
tumour characteristics. Analysis of overall melanoma incidence
rates demonstrated a steady rise in numbers detected over the five
years by 21% from 92 to 112 per 100,000 people per year. The
incidence of melanomas was slightly higher in women than in men
(109 versus 102 per 100 000), with higher incidence of diagnosed
melanomas in the older age groups (<30 years 13 per 100,000
compared to 253 per 100,000 for >65 years). The incidence of
melanoma decreased with increasing levels of deprivation
(‘least deprived’ group 132 per 100,000 versus 71 per 100,000 in
the ‘most deprived’ group). The majority (67%) of melanomas were
Table 1
Sample description and crude incidence rates.
n % Crude annual
incidence per
100,000 populationa
p-value
Total cases 11,611 100 21.2
Year 2006 2020 17.4 18.4 <0.001
2007 2142 18.4 19.5
2008 2499 21.5 22.8
2009 2500 21.5 22.8
2010 2450 21.1 22.3
Region East of England (total) 5998 51.7 21.0 0.226b
2006 1024 8.8 17.9
2007 1043 9.0 18.2
2008 1314 11.3 23.0
2009 1308 11.3 22.9
2010 1309 11.3 22.9
Scotland (total) 5613 48.3 21.4
2006 996 8.6 19.0
2007 1099 9.5 21.0
2008 1185 10.2 22.6
2009 1192 10.3 22.7
2010 1141 9.8 21.8
Sex Men 5481 47.2 20.5 0.217
Women 6130 52.8 21.9
Age <30 500 4.3 2.5 <0.001
30–49 1756 15.1 15.4
50–64 4208 36.2 31.4
>65 5147 44.3 50.5
Deprivation group 1 ‘‘least deprived’’ 3100 26.7 26.3 <0.001
2 2866 24.7 23.0
3 2693 23.2 21.4
4 1885 16.2 18.0
5 ‘‘most deprived’’ 1067 9.2 14.2
Breslow thickness <2 mm 7787 67.1 14.2 <0.001
2 mm 2868 24.7 5.2
Unknown 956 8.2 1.7
Histological type Superficial spreading 6221 53.6 11.3 <0.001
Nodular melanoma 1355 11.7 2.5
Lentigo maligna melanoma 1145 9.9 2.1
Unclassified melanoma 2116 18.2 3.9
Others 774 6.7 1.4
Anatomical site Trunk 3373 29.1 6.2 <0.001
Lower limb 3136 27.0 5.7
Upper limb 2482 21.4 4.5
Head and neck 2368 20.4 4.3
Unspecified and other sites 252 2.2 0.5
a Incidence rates based on 2008 population figures.
b p-value for test of differences by region base on aggregate test of East of England versus Scotland only and does not consider annual variation.
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cial spreading melanoma (54%). Slightly more melanomas were
located on the trunk (29%) and lower limbs (27%) than on the
upper limbs (21%) and head/neck areas (20%).
3.2. Seasonal variation in incidence
For the whole patient cohort, more melanomas were diagnosed
in the summer months (June 9.9%, July 9.7%, August 9.8%) than the
winter months (December 7.2%, January 7.2%, February 7.1%) and
this pattern was consistent for both regions studied. Seasonal
variation was evident when analysed by patient sex (particularly
among women) and age (most marked in those aged less than
50 years) (Table 2). Seasonal variation was also evident when
analysed by Breslow thickness, histological type and body site of
occurrence (Table 3).
Multivariate analysis showed that after adjusting for patient
and melanoma characteristics, there was very strong evidence(p < 0.001) of seasonal variability in melanoma diagnosis. The
average seasonal variability predicted from a model without
interaction terms is shown in Fig. 1 as rate ratios compared to 1st
January each year. There was substantial variation in incidence
over a year with rates over 30% higher in the summer months than
the winter months and a peak incidence occurring in July (peak to
peak rate ratio = 1.35 95% confidence interval (CI) 1.27, 1.43). This
analysis excluded those patients with missing Breslow thickness,
but similar patterns were seen in a model excluding tumour factors
on the full data set, indicating no obvious bias by using a complete
case analysis.
In multivariate analysis using interaction terms we found no
evidence that the seasonal variability was different for patients of
different ages (p = 0.51), deprivation (p = 0.56) or region (p = 0.56).
The seasonal variation by sex, Breslow thickness, body site and
histological type is shown in Fig. 2; there is evidence of each
being a moderating factor (p = 0.015 for sex, p = 0.002 for Breslow
thickness, p = 0.006 for body site, and p = 0.005 for histological
Table 2
Distribution of melanoma incidence (%) by month of diagnosis and patient demographics (n = 11,611).
Month of
diagnosis
Jan Feb Mar Apr May Jun Jul Aug Sept Oct Nov Dec
Frequency (%) 834 (7.18) 829 (7.14) 918 (7.91) 849 (7.31) 979 (8.43) 1151 (9.91) 1129 (9.72) 1138 (9.80) 971 (8.36) 1036 (8.92) 940 (8.10) 837 (7.21)
Sex
Men, % 390 (7.12) 396 (7.22) 436 (7.95) 382 (6.97) 452 (8.25) 529 (9.65) 502 (9.16) 555 (10.13) 441 (8.05) 489 (8.92) 465 (8.48) 444 (8.10)
Women, % 444 (7.24) 433 (7.06) 482 (7.86) 467 (7.62) 527 (8.60) 622 (10.15) 627 (10.23) 583 (9.51) 530 (8.65) 547 (8.92) 475 (7.75) 393 (6.41)
Age group
<50 yrs, % 228 (7.26) 213 (6.79) 272 (8.67) 248 (7.90) 280 (8.92) 287 (9.14) 333 (10.61) 308 (9.81) 267 (8.51) 262 (8.35) 232 (7.39) 209 (6.66)
50–64 yrs % 227 (6.83) 254 (7.64) 265 (7.97) 241 (7.25) 259 (7.79) 339 (10.20) 314 (9.44) 342 (10.29) 289 (8.69) 295 (8.87) 263 (7.91) 237 (7.13)
65–74 yrs % 185 (7.82) 169 (7.14) 173 (7.31) 155 (6.55) 195 (8.24) 236 (9.97) 216 (9.13) 242 (10.22) 177 (7.48) 229 (9.67) 216 (9.13) 174 (7.35)
75+ yrs % 194 (6.98) 193 (6.94) 208 (7.48) 205 (7.37) 245 (8.81) 289 (10.40) 266 (9.57) 246 (8.85) 238 (8.56) 250 (8.99) 229 (8.24) 217 (7.81)
Region
Scotland 402 (7.16) 400 (7.13) 459 (8.18) 404 (7.20) 487 (8.68) 559 (9.96) 505 (9.00) 550 (9.80) 472 (8.41) 494 (8.80) 476 (8.48) 405 (7.22)
Eastern
England
432 (7.20) 429 (7.15) 459 (7.65) 445 (7.42) 492 (8.20) 592 (9.87) 624 (10.40) 588 (9.80) 499 (8.32) 542 (9.04) 464 (7.74) 432 (7.20)
Deprivation quintiles
1 most
affluent %
227 (7.32) 209 (6.94) 243 (7.84) 229 (7.39) 270 (8.71) 300 (9.68) 309 (9.97) 315 (10.16) 245 (7.90) 293 (9.45) 244 (7.89) 216 (6.97)
2% 206 (7.19) 213 (7.43) 228 (7.96) 225 (7.85) 226 (7.89) 300 (10.47) 272 (9.49) 269 (9.39) 231 (8.06) 239 (8.34) 254 (8.86) 203 (7.08)
3% 188 (6.98) 196 (7.28) 203 (7.54) 188 (6.98) 244 (9.06) 273 (10.14) 282 (10.47) 257 (9.54) 247 (9.17) 241 (8.95) 187 (6.94) 187 (6.94)
4% 140 (7.43) 135 (7.16) 145 (7.69) 144 (7.64) 162 (8.59) 180 (9.55) 165 (8.85) 187 (9.92) 156 (8.82) 168 (8.91) 159 (8.44) 144 (7.64)
5 most
deprived %
73 (6.84) 76 (7,12) 99 (9.28) 63 (5.90) 77 (7.22) 98 (9.18) 101 (9.47) 110 (10.31) 92 (8.62) 95 (8.90) 96 (9.00) 87 (8.15)
F.M. Walter et al. / Cancer Epidemiology 39 (2015) 554–561 557type). Seasonal variation varied by histological type: while it
was distinct for superficial spreading melanoma (p = 0.005), there
was no evidence of differential seasonal patterns for other types
(p = 0.46). The final model also included two-way interactions
between sex and body site, sex and melanoma thickness, and body
site and thickness (p < 0.001 for all). Although ‘‘other/Unspecified’’
sites were included in the model we do not show the variation
due to small numbers and large uncertainties.
The starkest finding illustrated in Fig. 2 is that the seasonal
variation is around twice as large for melanomas arising on the
limbs than those arising on the head, neck or trunk. There was
evidence of a larger seasonal variation in women than in men.
The difference between thinner and thicker melanomas was
small, with the peak occurrence of thicker melanomas occurring
slightly earlier than the summer months. Each line is plotted
individually with confidence intervals in online Appendix 1. All
of the 32 individual lines are statistically significant (p < 0.05)
with the exception of two where the variation is weak (non-
superficial spreading, thin melanomas, occurring in men on the
head/neck (p = 0.44) or trunk (p = 0.29)). The trend for thicker
melanomas to have a peak occurrence earlier in the year than
thinner ones is also evident in the supplementary analysis
splitting thickness into four categories (online Appendix 2).
4. Discussion
4.1. Main findings
This is the first study to compare and contrast seasonal
variation in the diagnosis of cutaneous melanoma across English
and Scottish populations, and it showed stronger seasonal
variation in incidence than the previously reported Northern Irish
data analysis. Seasonal variation was evident when analysed by
sex, age, Breslow thickness, histological type and body site of
occurrence. Seasonal variation was more marked in women and
younger people in both regions, and was significantly greater on
both the upper and lower limbs compared with the trunk and
head/neck, in thinner (<2 mm) compared to thicker (2 mm)
melanomas, and in superficial spreading melanomas compared
with other histological types.4.2. Comparison with existing literature
Our results contrast notably with those of Chaillol and
colleagues [11], based on Northern Ireland Cancer Registry data,
which only found seasonal variation in women with thin
melanomas arising on the limbs. They did not observe seasonal
variation in older men, thinner melanomas arising on the trunk,
head or neck, or any thicker melanomas irrespective of age, sex and
body site. The reasons for this contrast with our results are unclear,
although the sample size of the Northern Irish study was five-fold
smaller, therefore there may have not been enough power to detect
such associations. The issue of power was further compounded by
the stratified approach they took rather than the approach of using
interactions that we have employed. Furthermore, our data were
collected between 2006 and 2010 (compared with Challiol et al’s
analyses using data from cases diagnosed between 1984 and
2006), so that important differences in more recent patterns of
UV exposure, social conventions regarding exposure of the skin,
and help-seeking behaviour for skin changes in earlier decades,
may also play a role.
Chaillol et al. also undertook a systematic literature review of
studies examining whether seasonal variations were associated
with sex, age, body site, histological type or Breslow thickness.
They identified 15 studies (Europe (Norway, Germany, Greece,
Italy, UK) 7, USA 5, Australia 2, Brazil 1) reporting data from 281 to
32,868 melanoma cases diagnosed between 1960 and 2006 [8–10,
12–23]. Overall, they found that seasonal variations were more
marked in women than men, in younger ages, and on the limbs
more than the trunk or head and neck; our findings are strikingly
similar. Seven studies reported greatest seasonal variation in
superficial spreading melanomas, with three studies also reporting
seasonal variation with lentigo maligna melanomas. Five studies
found seasonal variation in thin lesions with none in thick lesions,
while one Greek study found no seasonal variation with Breslow
thickness. A more recent study by Keller and colleagues [24], set in
Bavaria in Germany and analysing 11,901 malignant melanomas
registered from 2003 to 2008 again shows contrasting results: in
this population seasonal variation was most evident in thicker
(2 mm) melanomas on the limbs. The only other previous study
set in the UK reported the month of first attendance (rather than
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Fig. 1. The average seasonal variability in melanoma incidence predicted from a
model without interaction terms.
F.M. Walter et al. / Cancer Epidemiology 39 (2015) 554–561558the month of histological diagnosis) of the 1019 melanomas
registered by the Oxford Cancer Registry between 1952 and 1975
[10]. It showed peak months of presentation between July and
September for men and women, most marked in people aged less
than 55, both corresponding with our findings.
We report monthly figures showing pronounced seasonal
variation, which may be influenced by a number of factors. UV
exposure is likely to be important: not only are the limbs more
likely to be visible in the summer months through wearing of
short-sleeved tops, and shorts or skirts, but they are concomitantly
more exposed to UV radiation. The causal effects of UV exposure on
melanoma are well documented, as economic and social changes
in recent years have contributed to increased sun exposure during
holidays and outdoor sports, and the widespread use of indoor
tanning [25–27]. While initiation of a melanoma seems unlikely
to occur within a short interval following exposure, there is
increasing evidence that short sun exposures can also promote
rapid pathological changes in existing lesions which may result
in visible changes, thereby contributing to seasonal variations in
help-seeking and subsequent detection [24].
The visibility of the lesion is also likely to be a major
contributing factor: lighter or less clothing worn on the limbs in
the spring and summer months allows people to appraise their
own skin more easily. It could have been hypothesised that
enhanced visibility might lead to an ‘earlier harvesting’ of lesions
that would have otherwise been diagnosed later in the year;
however, the findings considering monthly variation by melanoma
thickness (see Table 3, top super-row) indicate that thicker
melanomas have a slightly earlier peak presentation than thinner
ones. Visible lesions may also be appraised by others, particularly
family members, friends and work colleagues, as well as
opportunistically by healthcare professionals. Recent qualitative
evidence suggests the importance of people’s social network in
prompting help-seeking for melanoma [28], while living alone is
associated with longer patient delays in diagnosis with other
cancers [29]. Although less marked than for the limbs, variation
was observed for lesions on the trunk for both males and females,
likely reflecting increased exposure during warmer weather or
while on holiday. We found least seasonal variation in melanomas
on the head and neck which is unsurprising given high visibility of
these areas throughout the year. However, seasonal variation has
also been described in countries where lightweight clothing is
worn all year round; a Hawaiian study demonstrated seasonal
variations for head and neck lesions, which would be expected to
show less changes in visibility compared with lesions on the trunk
and limbs [13]. This suggests that the impact of the visibility of the
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F.M. Walter et al. / Cancer Epidemiology 39 (2015) 554–561560lesion on seasonal variations in melanoma diagnosis is complex,
and other factors may also be important. Previous research from
an Italian cohort has indicated an excess risk of melanoma and
other skin cancer for people born in Spring or Autumn months [30],
which nonetheless would not explain the patterns of excess risk in
the summer months observed in our study.
4.3. Strengths and weaknesses of the study
The main strength of this study is that it used population-based
data of high quality and completeness from two regions covering
>10 million UK population. The most important prognostic factor,
the Breslow thickness, was reported in millimetres for about 90%
of the cohort. Furthermore, we were able to robustly account for
potential confounding of seasonal variation by patient or tumour
case-mix; in addition we examined the potential effect modifica-
tion by the same factors.
This report has a number of limitations inherent in observa-
tional studies. Most importantly, the data are based on the
accuracy of the information recorded at the National Cancer
Registration Service and the Scottish Cancer Registry. We are not
able to comment on time to presentation to the GP, or time from
first seeing their GP to referral and histological diagnosis, as these
data are not collected routinely by the registries – however it is
highly unlikely that access to GPs and referral waiting times will
exhibit such pronounced patterns of seasonal variation that would
be necessary to explain the observed findings. We acknowledge
that data from the two registries may not reflect national data, but
suggest that the findings are unlikely to differ greatly in other UK
regions.
4.4. Implications for practice and future research
Although there remains insufficient evidence for the introduc-
tion of national skin cancer screening programmes [31], a recent
review suggested that melanoma early detection programmes
aimed at high-risk individuals might be cost-effective [32]. Until
then, raising awareness of skin cancer to promote timely diagnosis
is vital [33]. Skin cancer awareness campaigns need not only to
provide information on the early signs and symptoms that should
prompt help-seeking (as well as encouragement to seek advice),
but could capitalise on evidence of seasonal variation in diagnosis,
which indicates that at least part of the population are more ‘skin-
aware’ and show greater readiness for seeking medical help for
suspected skin lesions during the summer months. This does not of
course negate the need for ‘skin awareness’ throughout the year.
The beneficial role of friends and relatives in encouraging help-
seeking behaviours in those who have a skin lesion has been
documented [28,34]. There is evidence that such sanctioning of
help seeking by others can be an important factor in reduced time
to presentation [29,35], and again there is potential for skin cancer
awareness campaigns to capitalise on this, particularly during the
summer months. Similarly, there is scope for interventions among
non-clinician professionals such as salon workers, chiropractors
and others [36,37].
In conclusion, contemporary evidence from a large and
geographically diverse population of UK patients with melanoma
indicates notable seasonal variation in diagnosis, most likely
demonstrating concordant seasonal variation in awareness of skin
changes on self or others, and related help-seeking behaviour.
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